Zydus Lifesciences completes 50:50 JV with Sunshine Healthcare Lanka
In short
Zydus Lifesciences completed its 50:50 joint venture with Sunshine Healthcare Lanka on November 11. BusinessLine said the partners had extended the original closing timeline under their June agreement.
The deal formally puts the partnership in place and links the two companies in Sri Lanka.
What the reporting says
Zydus Lifesciences completed its 50:50 joint venture with Sunshine Healthcare Lanka on November 11, after the partners extended the original closing timeline under their June agreement. BusinessLine reported the completion of the transaction following that extension. The deal formalizes the partnership between the two companies in Sri Lanka.
Why it matters
Zydus Lifesciences completed a 50:50 joint venture with Sunshine Healthcare Lanka on November 11. BusinessLine said the partners had extended the original closing timeline under their June agreement before completing the transaction. The deal formalizes a joint business structure in Sri Lanka and gives Zydus a clearer operating tie-up in the local healthcare market.